Skip to main content

The latest developments on the gene therapy frontier

As record levels of money pour into gene therapy research, biotechs are under pressure to answer questions on safety, delivery and pipelines. Gene therapy is once again at the forefront of biomedical research, catalyzed by advances in safer delivery of genes to cells.

included in this trendline
  • 5 questions facing gene therapy in 2022
  • Undeterred by gene therapy’s struggles, a startup launches into a downturn
  • Bluebird, after warning of dwindling cash, to lay off 30% of workforce
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.